About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD26.04
- USD26.90
- USD26.02
- USD44.32
- 15.00%
- 218M
- 4.20M
- 2.73M
- 5.2B
- 21.62
- -30.70%
Stock News
2 hours ago
Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.
MarketWatch
3 hours ago
BNP Paribas Signs €5.1 Billion Deal to Buy Axa’s Asset Manager
Yahoo
4 hours ago
The Returns At Cigna Group (NYSE:CI) Aren't Growing
Yahoo
5 hours ago
Billionaire Paul Tudor Jones' Fund Just Sold Boeing and Bought This Popular Cryptocurrency Instead
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
